PubMed:27277809 / 2196-2486 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PubMed/sourceid/27277809","sourcedb":"PubMed","sourceid":"27277809","text":"The current study provides preclinical evidence that a Food and Drug Administration-approved drug, dimethylfumarate (DMF), and its metabolite monomethylfumarate (MMF) can block nigrostriatal dopaminergic neurodegeneration in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of PD.","tracks":[{"project":"Inflammaging","denotations":[{"id":"T13","span":{"begin":0,"end":290},"obj":"Sentence"},{"id":"T13","span":{"begin":0,"end":290},"obj":"Sentence"}],"attributes":[{"subj":"T13","pred":"source","obj":"Inflammaging"},{"subj":"T13","pred":"source","obj":"Inflammaging"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"Inflammaging","color":"#93eccf","default":true}]}]}}